| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.3 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.4 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |